BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2017
View Archived Issues
Bonti secures series B financing to support development of EB-001
Read More
Phase III trial studies Solucin for neuroendocrine tumors of gastroenteric or pancreatic origin
Read More
BAY-1895344: a potent candidate for DNA damage-related tumors
Read More
New phase III trial explores use of nintedanib in progressive fibrosing lung conditions
Read More
Abeome and CDC establish Zika collaboration
Read More
Parvus signs license and collaboration agreement with Novartis in type 1 diabetes
Read More
A-395 is a first-in-class antagonist of PRC2 protein-protein interactions
Read More
H3 Biomedicine identifies selective estrogen receptor covalent antagonist H3B-6545 for breast cancer
Read More
Results from the TRUE-AHF trial of ularitide in patients with acute heart failure
Read More
Bicycle reports preclinical milestone under ThromboGenics ophthalmology alliance
Read More
AbbVie initiates phase III study of ABT-494 for psoriatic arthritis
Read More
New chewable tablet formulation of Vyvanse available in U.S.
Read More
MedImmune begins first-in-human study of MEDI-5083 alone and with durvalumab in solid tumors
Read More
Phase I/IIa trial of FOL-005 demonstrates stimulation of hair growth in healthy volunteers
Read More
Vernalis and Servier patent DYRK1 and CLK1 inhibitors
Read More
Lion Biotechnologies and MD Anderson establish TIL therapy alliance
Read More
Oncochel Therapeutics identifies thiosemicarbazone iron chelators
Read More
Oragenics provides update regarding AG-013 and OG-716
Read More
Xenon Pharmaceuticals and Genentech present Nav1.7 channel blockers
Read More
Johnson & Johnson reports key milestones of first quarter 2017
Read More
Incyte discovers Pim kinases inhibitors
Read More
Zejula now available in U.S.
Read More
BioCryst Pharmaceuticals presents plasma kallikrein inhibitors
Read More
Qu Biologics reports response and remission rates from trial of Qbeco in Crohn's disease
Read More
PLx Pharma completes merger with Dipexium Pharmaceuticals
Read More
Phase III studies of veliparib in NSCLC and TNBC did not meet primary endpoints
Read More
Cancer Research UK, CPF and NCI collaborate to target RAS
Read More